Annual report pursuant to Section 13 and 15(d)

Schedule of Segments (Tables)

v3.8.0.1
Schedule of Segments (Tables)
12 Months Ended
Dec. 31, 2016
Schedule of Segments (Tables)  
Schedule of Segment Reporting Information, by Segment

The Company also has certain small cancer related legacy investments and an investment in note receivable from a non-affiliated party that is included in the Corporate and Eliminations section below:

 

 

Cannabis and

Medical

Marijuana

Segment

Trash

Management

Corporate

and

Eliminations

Consolidated

2016

 

 

 

 

 

 

 

 

Net sales

$

-

$

2,740,187

$

21,058

$

2,761,245

Operating income (loss)

 

(50,043)

34,485

(880,416)

(895,974)

Interest income

 

10,958

 

1

 

103,877

 

114,836

Interest expense

 

-

17,275

23,350

40,625

Total assets

 

1,632,055

1,119,407

2,627,137

5,378,599

Property additions

 

-

29,210

1,029

30,239

Depreciation and amortization

 

295

21,752

3,715

25,762

 

2015

 

Net sales

$

98,533

$

2,463,225

$

-

$

2,561,758

Operating income (loss)

 

(5,373)

122,488

(889,328)

(772,213)

Interest income

 

9,318

 

-

 

65,732

 

75,050

Interest expense

 

-

18,910

(3,278)

15,632

Total assets

 

1,673,616

1,131,481

1,469,964

4,275,061

Property additions

 

2,026

9,959

6,036

18,021

Depreciation and amortization

 

1,568

30,004

3,783

35,355